TP53 and ovarian carcinoma: In addition, PI was used to stain ovarian cancer cell nuclei in samples from 50 patients, and the incidence of polyploidy and aneuploidy in the TP53 mutant group was much higher than that in the wild-type group (p < 0.01) (Fig. 3c).